{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T14:07:17Z","timestamp":1655302037279},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1007\/s11906-000-0032-0","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T05:53:31Z","timestamp":1179986011000},"page":"482-489","source":"Crossref","is-referenced-by-count":5,"title":["Atherosclerotic renal artery stenosis: Surgery, percutaneous transluminal angioplasty, or medical therapy?"],"prefix":"10.1007","volume":"2","author":[{"given":"Pierre-Fran\u00e7ois","family":"Plouin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Gu\u00e9ry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s La Batide","family":"Alanore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"32_CR1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.320.7242.1124","volume":"320","author":"K McLaughlin","year":"2000","unstructured":"McLaughlin K, Jardine AG, Moss JG: Renal artery stenosis. BMJ 2000, 320:1124\u20131127.","journal-title":"BMJ"},{"key":"32_CR2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0741-5214(93)90340-R","volume":"18","author":"H Weibull","year":"1993","unstructured":"Weibull H, Bergqvist D, Bergentz SE, et al.: Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 1993, 18:841\u2013852. This randomized trial in patients with ostial ARAS showed that PTRA and operation did not differ significantly in their effects on renal artery patency, renal function, and blood pressure. The authors concluded that PTRA is recommended as first-choice of therapy for ARAS.","journal-title":"J Vasc Surg"},{"key":"32_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM199702133360702","volume":"336","author":"U Blum","year":"1997","unstructured":"Blum U, Krumme B, Fl\u00fcgel P, et al.: Treatment of ostial renalartery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997, 336:459\u2013465.","journal-title":"N Engl J Med"},{"key":"32_CR4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.CIR.98.7.642","volume":"98","author":"G Dorros","year":"1998","unstructured":"Dorros G, Jaff M, Mathiak L, et al.: Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998, 98:642\u2013647. This cohort study describes the early complications and long-term outcome of stent revascularization performed on 163 patients with ARAS for resistant hypertension or preservation of renal function. Survival was adversely affected by renal dysfunction despite adequate revascularization.","journal-title":"Circulation"},{"key":"32_CR5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.300.6724.569","volume":"300","author":"LE Ramsay","year":"1990","unstructured":"Ramsay LE, Waller PC: Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ 1990, 300:569\u2013572.","journal-title":"BMJ"},{"key":"32_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0895-7061(98)00201-5","volume":"12","author":"MJ Bloch","year":"1999","unstructured":"Bloch MJ, Trost DW, Pickering TG, et al.: Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens 1999, 12:1\u20137.","journal-title":"Am J Hypertens"},{"key":"32_CR7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-118-9-199305010-00010","volume":"118","author":"JM Rimmer","year":"1993","unstructured":"Rimmer JM, Gennari FJ: Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993, 118:712\u2013719.","journal-title":"Ann Intern Med"},{"key":"32_CR8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.jhh.1000599","volume":"12","author":"J Webster","year":"1998","unstructured":"Webster J, Marshall F, Abdalla M, et al.: Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998, 12:329\u2013335.","journal-title":"J Hum Hypertens"},{"key":"32_CR9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.HYP.31.3.823","volume":"31","author":"PF Plouin","year":"1998","unstructured":"Plouin PF, Chatellier G, Darne B, et al.: Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998, 31:823\u2013829. This randomized trial compared medication to PTRA in patients with unilateral ARAS. Twenty-four-hour ambulatory blood pressure, the primary outcome, did not differ between the control and PTRA groups at 6 months.","journal-title":"Hypertension"},{"key":"32_CR10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0140-6736(98)04432-8","volume":"353","author":"PJ Ven van de","year":"1999","unstructured":"van de Ven PJ, Kaatee R, Beutler JJ, et al.: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999, 353:282\u2013286. In this randomized trial in patients with ostial ARAS, stenting was better than PTRA alone for achieving renal artery patency, but blood pressure and plasma creatinine levels did not differ at 6 months between treatment groups","journal-title":"Lancet"},{"key":"32_CR11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM200004063421403","volume":"342","author":"BC Jaarsveld van","year":"2000","unstructured":"van Jaarsveld BC, Krijnen P, Pieterman H, et al.: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000, 342:1007\u20131014. This relatively large (n =106), carefully analyzed randomized trial concluded that PTRA has little advantage over medical therapy in patients with ARAS. The blood pressure results were not related to the severity of renal artery stenosis at randomization. In the PTRA group, abnormal findings on renal scintigraphy at entry did not predict blood pressure outcome.","journal-title":"N Engl J Med"},{"key":"32_CR12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.1998.37","volume":"53","author":"SC Textor","year":"1998","unstructured":"Textor SC: Revascularization in atherosclerotic renal artery disease. Kidney Int 1998, 53:799\u2013811. A comprehensive review of the clinical presentation, epidemiology, pathophysiology, and therapy of ARAS.","journal-title":"Kidney Int"},{"key":"32_CR13","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1681\/ASN.V2111608","volume":"2","author":"MB Harding","year":"1992","unstructured":"Harding MB, Smith LR, Himmelstein SI, et al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992, 2:1608\u20131616.","journal-title":"J Am Soc Nephrol"},{"key":"32_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.STR.31.1.61","volume":"31","author":"S Kuroda","year":"2000","unstructured":"Kuroda S, Nishida N, Uzu T, et al.: Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke 2000, 31:61\u201365.","journal-title":"Stroke"},{"key":"32_CR15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0272-6386(97)90127-X","volume":"29","author":"T Uzu","year":"1997","unstructured":"Uzu T, Inoue T, Fujii T, et al.: Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 1997, 29:733\u2013738.","journal-title":"Am J Kidney Dis"},{"key":"32_CR16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0002-9343(94)90109-0","volume":"96","author":"CG Missouris","year":"1994","unstructured":"Missouris CG, Buckenham T, Cappuccio FP, et al.: Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med 1994, 96:10\u201314.","journal-title":"Am J Med"},{"key":"32_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(97)11060-1","volume":"352","author":"P MacDowall","year":"1998","unstructured":"MacDowall P, Kalra PA, O\u2018Donoghue DJ, et al.: Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998, 352:13\u201316.","journal-title":"Lancet"},{"key":"32_CR18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/003693309003500303","volume":"35","author":"C Isles","year":"1990","unstructured":"Isles C, Main J, O\u2018Connell J, et al.: Survival associated with renovascular disease in Glasgow and Newcastle: a collaborative study. Scott Med J 1990, 35:70\u201373.","journal-title":"Scott Med J"},{"key":"32_CR19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1681\/ASN.V92252","volume":"9","author":"PJ Conlon","year":"1998","unstructured":"Conlon PJ, Athirakul K, Kovalik E, et al.: Survival in renal vascular disease. J Am Soc Nephrol 1998, 9:252\u2013256.","journal-title":"J Am Soc Nephrol"},{"key":"32_CR20","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/00004872-199917120-00012","volume":"17","author":"M Johansson","year":"1999","unstructured":"Johansson M, Herlitz H, Jensen G, et al.: Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999, 17:1743\u20131750. A study of long-term survival and causes of death in hypertensive patients with ARAS. Reduced renal function and age were independent predictors of death. During the 7.1-year follow-up period, a majority of deaths were due to cardiovascular disease.","journal-title":"J Hypertens"},{"key":"32_CR21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0272-6386(00)70328-3","volume":"35","author":"A Losito","year":"2000","unstructured":"Losito A, Parente B, Cao PG, et al.: ACE gene polymorphism and survival in atherosclerotic renovascular disease. Am J Kidney Dis 2000, 35:211\u2013215.","journal-title":"Am J Kidney Dis"},{"key":"32_CR22","first-page":"413","volume":"87","author":"JO Connolly","year":"1994","unstructured":"Connolly JO, Higgins RM, Walters HL, et al.: Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. Q J Med 1994, 87:413\u2013421.","journal-title":"Q J Med"},{"key":"32_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1523-1755.1998.00968.x","volume":"54","author":"A Meyrier","year":"1998","unstructured":"Meyrier A, Hill GS, Simon P: Ischemic renal disease: new insights into old entities. Kidney Int 1998, 54:2\u201313.","journal-title":"Kidney Int"},{"key":"32_CR24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/ajkd.1998.v31.pm9631841","volume":"31","author":"K Baboolal","year":"1998","unstructured":"Baboolal K, Evans C, Moore RH: Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 1998, 31:971\u2013977.","journal-title":"Am J Kidney Dis"},{"key":"32_CR25","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1046\/j.1523-1755.1999.07126.x","volume":"71","author":"JE Scoble","year":"1999","unstructured":"Scoble JE: Atherosclerotic nephropathy. Kidney Int Suppl 1999, 71:S106-S109.","journal-title":"Kidney Int Suppl"},{"key":"32_CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1475-097X.1992.tb00304.x","volume":"12","author":"K Nielsen","year":"1992","unstructured":"Nielsen K, Relhing M, Henriksen JH: Renal vein oxygen saturation in renal artery stenosis. Clin Physiol 1992, 12:179\u2013184.","journal-title":"Clin Physiol"},{"key":"32_CR27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/00004872-199511000-00016","volume":"13","author":"JM Halimi","year":"1995","unstructured":"Halimi JM, Ribstein J, Du Cailar G, et al.: Albuminuria predicts renal functional outcome after intervention in atheromatous renovascular disease. J Hypertens 1995, 13:1335\u20131342.","journal-title":"J Hypertens"},{"key":"32_CR28","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1161\/01.CIR.98.25.2866","volume":"98","author":"MT Caps","year":"1998","unstructured":"Caps MT, Perissinotto C, Zierler RE, et al.: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998, 98:2866\u20132872. This large cohort study analyzed the incidence of and the risk factors associated with progression of renal artery disease over 33 months in patients with ARAS. Progression of renal artery disease was frequent but total renal artery occlusion was rare.","journal-title":"Circulation"},{"key":"32_CR29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1523-1755.1998.00805.x","volume":"53","author":"MT Caps","year":"1998","unstructured":"Caps MT, Zierler RE, Polissar NL, et al.: Prospective study of atherosclerotic disease progression in the renal artery. Kidney Int 1998, 53:735\u2013742. This analysis is from the same cohort as in reference 28 and complements that study. Renal atrophy was frequent in high-grade stenosis and well correlated with changes in serum creatinine level.","journal-title":"Kidney Int"},{"key":"32_CR30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0741-5214(98)70195-8","volume":"28","author":"WK Williamson","year":"1998","unstructured":"Williamson WK, Abou-Zamzam AM Jr, Moneta GL, et al.: Prophylactic repair of renal artery stenosis is not justified in patients who require infrarenal aortic reconstruction. J Vasc Surg 1998, 28:14\u201320.","journal-title":"J Vasc Surg"},{"key":"32_CR31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.21.1.89","volume":"21","author":"PF Plouin","year":"1993","unstructured":"Plouin PF, Darn\u00e9 B, Chatellier G, et al.: Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension 1993, 21:89\u201396.","journal-title":"Hypertension"},{"key":"32_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/qjmed\/92.3.159","volume":"92","author":"CG Isles","year":"1999","unstructured":"Isles CG, Robertson S, Hill D: Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med 1999, 92:159\u2013167. A recent and detailed analysis of 10 stent studies, including technical aspects, complications, and blood pressure and renal function at baseline and during follow-up.","journal-title":"Q J Med"},{"issue":"suppl 2","key":"32_CR33","first-page":"S194","volume":"16","author":"MA Pohl","year":"1998","unstructured":"Pohl MA, Ali S, Novick AC, et al.: Renal function does not deteriorate rapidly (< 6 months) in patients with high grade atherosclerotic renal artery stenosis. J Hypertens 1998, 16(suppl 2):S194.","journal-title":"J Hypertens"},{"key":"32_CR34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0140-6736(05)60262-0","volume":"352","author":"CKT Farmer","year":"1998","unstructured":"Farmer CKT, Reidy J, Kalra PA, et al.: Individual kidney function before and after angioplasty. Lancet 1998, 352:288\u2013289.","journal-title":"Lancet"},{"key":"32_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet Trialists\u2018 Collaboration","year":"1994","unstructured":"Antiplatelet Trialists\u2018 Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994, 308:81\u2013106.","journal-title":"BMJ"},{"key":"32_CR36","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L, Zanchetti A, Carruthers SG, et al.: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755\u20131762.","journal-title":"Lancet"},{"key":"32_CR37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","volume":"341","author":"RH Knopp","year":"1999","unstructured":"Knopp RH: Drug treatment of lipid disorders. N Engl J Med 1999, 341:498\u2013511.","journal-title":"N Engl J Med"},{"key":"32_CR38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(99)07330-4","volume":"355","author":"JA Staessen","year":"2000","unstructured":"Staessen JA, Gasowski J, Wang JG, et al.: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000, 355:865\u2013872.","journal-title":"Lancet"},{"key":"32_CR39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, et al.: Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:145\u2013153.","journal-title":"N Engl J Med"},{"key":"32_CR40","first-page":"151","volume":"17","author":"Guidelines Subcommittee","year":"1999","unstructured":"Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999, 17:151\u2013183.","journal-title":"J Hypertens"},{"key":"32_CR41","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1523-1755.1998.00840.x","volume":"53","author":"PJ Ven van de","year":"1998","unstructured":"van de Ven PJ, Beutler JJ, Kaatee R, et al.: Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int 1998, 53:986\u2013993. A prospective evaluation of the safety of ACE inhibitors in patients with ARAS. The authors also studied whether changes in renal function after ACE inhibitor therapy can be used to identify patients with significant bilateral ARAS among those at risk.","journal-title":"Kidney Int"},{"key":"32_CR42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-115-7-513","volume":"115","author":"RD Toto","year":"1991","unstructured":"Toto RD, Mitchell HC, Lee HC, et al.: Reversible renal insufficiency due to angiotensin-converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Intern Med 1991, 115:513\u2013519.","journal-title":"Ann Intern Med"},{"key":"32_CR43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/ajh\/1.4.359","volume":"1","author":"I Miyamori","year":"1988","unstructured":"Miyamori I, Yasuhara S, Matsubara T, et al.: Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension. Am J Hypertens 1988, 1:359\u2013363.","journal-title":"Am J Hypertens"},{"key":"32_CR44","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.1995.196","volume":"47","author":"A Imamura","year":"1995","unstructured":"Imamura A, Mackenzie HS, Lacy ER, et al.: Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats. Kidney Int 1995, 47:1394\u20131402.","journal-title":"Kidney Int"},{"key":"32_CR45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ajh\/3.5.360","volume":"3","author":"DHP Streeten","year":"1990","unstructured":"Streeten DHP, Anderson GH, Wagner S: Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens 1990, 3:360\u2013365.","journal-title":"Am J Hypertens"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-000-0032-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-000-0032-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-000-0032-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T03:12:06Z","timestamp":1628910726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-000-0032-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s11906-000-0032-0","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}